Ceva has announced details of what it calls a "new wave of innovation", driven by vaccines designed to help poultry producers overcome some of their biggest current challenges.
The firm said producers looking for long-term success need to focus on innovation centred around antibiotic-free production and stringent welfare practices. It has recently invested in diagnostic work, data analysis, personalised on-farm audits and other processes to find solutions to day-to-day obstacles in these areas.
“Ceva has announced new vaccines designed to help poultry producers meet targets such as antibiotic-free production.“
Concrete developments coming out of this investment include a new generation of double-insert vector vaccines against Newcastle disease and infectious bursal disease.
Ceva also announced a range of coccidiosis vaccines for broilers, breeders and turkeys: Immucox 3, Immucox 5 and Immucox T.
Dr Sylvain Comte, head of poultry at the firm, said these innovations will help to meet "the joint needs of consumers and the poultry producers" by making farms healthier and less exposed to bacterial infections.
He added: "Ceva will continue to contribute to improved bird health status and help the industry to face the new challenges of antibiotic-free production."
With over 20 years of experience within the animal health market, we at Zenopa have the knowledge, skills and expertise to help find the right job for you. To find out more about the current animal health roles we have available, you can search for the latest job roles, register your details, or contact the team today.See all the latest jobs in Animal Health